GENERI BIOTECH s.r.o.

Machkova 587, 50011 Hradec Kralove
Czechia
Telephone +420 495 056314
info@generi-biotech.com
http://www.generi-biotech.com

Product Categories

Product categories

03 Diagnostic Tests
03.06 Genetic testing, molecular diagnostics
03.06.01 DNA testing

DNA testing

BCR-ABL1 detection / IVD kits for oncology
gb ONCO BRAF (V600E)
IVD kits for pharmacogenetics
gb PHARM TPMT
gb PHARM CYP2C19
IVD kits for human genetics
gb GENETIC HFE
gb GENETIC LACTO
IVD kits for thrombophilic mutations
gb HEMO FV (G1691A)
gb HEMO PAI1 (4G/5G)
gb MICRO Aspergillus

03 Diagnostic Tests
03.06 Genetic testing, molecular diagnostics
03.06.03 Polymerase chain reaction (PCR)

Polymerase chain reaction (PCR)
Our products

Product category: DNA testing
BCR-ABL1 detection / IVD kits for oncology
In the category of CE IVD kits for oncology, we present our comprehensive portfolio of products for one-step real-time RT-PCR detection and quantification of BCR-ABL1 fusion transcripts.

Product category: DNA testing
gb ONCO BRAF (V600E)
The CE IVD kit used to detect and quantify the BRAF V600E, E2, D somatic mutation in human genomic DNA. The detection principle is based on real-time PCR using fluorescently labeled probes and allele specific primers.

Product category: DNA testing
IVD kits for pharmacogenetics
We develop and produce CE IVD real-time PCR kits that are used for in vitro genotypization before an appropiate treatment of disease starts.

Product category: DNA testing
gb PHARM TPMT
The CE IVD real-time PCR kit intended for detection of TPMT*2, TPMT*3A, TPMT*3B and TPMT*3C in TPMT gene in human genomic DNA by real-time PCR method (allelic discrimination).

Product category: DNA testing
gb PHARM CYP2C19
The CE IVD real-time PCR kit intended for detection of CYP2C19*2, CYP2C19*3 and CYP2C19*17 gene mutation. The detection principle is based on a real-time PCR method (allelic discrimination).

Product category: DNA testing
IVD kits for human genetics
CE IVD real-time PCR kits for genetics are being used for examination of the most common monogenic diseases of clinical significance.

Product category: DNA testing
gb GENETIC HFE
The CE IVD real-time PCR kit intended for detection of mutations C282Y, H63D and S65C in the gene HFE in human genomic DNA. Detection is based on real-time PCR method (allelic discrimination).

Product category: DNA testing
gb GENETIC LACTO
The CE IVD kit intended for detection of mutations LCT (C13910T) and LCT (G22018A) in the lactase gene in human genomic DNA. Detection is based on real-time PCR method (allelic discrimination).

Product category: DNA testing
IVD kits for thrombophilic mutations
We present a comprehensive portfolio of “thrombophilic” CE IVD real-time PCR kits: starting with extensively used FII and FV detection kits to very special kits such as PAI1 and EPCR kits

Product category: DNA testing
gb HEMO FV (G1691A)
The CE IVD kit intended for detection of mutation G1691A (Leiden) in coagulation factor V in human genomic DNA. Detection is based on real-time PCR method (allelic discrimination).

Product category: DNA testing
gb HEMO PAI1 (4G/5G)
The CE IVD kit intended for detection of mutation 4G/5G in PAI1 gene promotor in human genomic DNA. Detection is based on real-time PCR method (allelic discrimination).

Product category: DNA testing
gb MICRO Aspergillus
The CE IVD real-time PCR kit intended for detection and quantification of pathogenic DNA of the most commonly occurring species of Aspergillus – A. fumigatus, A. flavus, A. niger and A. terreus by real-time PCR method.

ad: contact information

About Us

Company details
GENERI BIOTECH s.r.o. is a Czech biotechnological company focusing its development, manufacturing and services on:

manufacture of in vitro diagnostic kits for molecular biology | ISO 13485

IVD kits lines:
ONCO – kits for oncology
PHARM – kits for detection of pharmacogenetically important mutations
HEMO – kits for detection of thrombophilic mutations
GENETIC – kits for medical genetics
MICRO – kits for detection of microorganisms

manufacture of products for molecular biology | ISO 9001

Product lines:
oligonucleotides
qPCR probes
PCR reagents
DNA extraction kits

testing and QC services | ISO/IEC 17025, GLP, GMP

for market segment: pharma/biotech
testing for drug development in the phases: drug discovery, preclinical and clinical testing
quality control in pharmaceutical production of biologicals

for market segment: science
cytotoxicity testing
cell lines authentication
detection of mycoplasma

for market segment: public
paternity testing
testing of genetic origin

for market segment: government institutions
expert institute services

Less
Company data
Number of employees

20-49
Foundation

1995
Area of business

Diagnostics

ad: company

EXBIO Praha, a.s.
FANSKI.s.r.o
GAMA GROUP A.S.
Global Biomedica s.r.o.
Grade Medical s.r.o.
Institut pro testování a certifikaci,a.s
GAMA GROUP A.S.
FANSKI.s.r.o
EXBIO Praha, a.s.
Exatherm, Ltd.
EMBITRON s.r.o.

Global Biomedica s.r.o.
Grade Medical s.r.o.
Institut pro testování a certifikaci,a.s
Agilent Technologies Denmark ApS
Acurail ApS